These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 17612851)
1. Neuropsychiatric complications of interferons: classification, neurochemical bases, and management. Malek-Ahmadi P; Hilsabeck RC Ann Clin Psychiatry; 2007; 19(2):113-23. PubMed ID: 17612851 [TBL] [Abstract][Full Text] [Related]
2. Mood symptoms during corticosteroid therapy: a review. Brown ES; Suppes T Harv Rev Psychiatry; 1998; 5(5):239-46. PubMed ID: 9493946 [TBL] [Abstract][Full Text] [Related]
3. Mood disorders associated with interferon treatment: theoretical and practical considerations. Malek-Ahmadi P Ann Pharmacother; 2001 Apr; 35(4):489-95. PubMed ID: 11302414 [TBL] [Abstract][Full Text] [Related]
4. The psychiatric side effects of corticosteroids. Brown ES; Khan DA; Nejtek VA Ann Allergy Asthma Immunol; 1999 Dec; 83(6 Pt 1):495-503; quiz 503-4. PubMed ID: 10619339 [TBL] [Abstract][Full Text] [Related]
10. Adverse psychological effects of corticosteroids in children and adolescents. Stuart FA; Segal TY; Keady S Arch Dis Child; 2005 May; 90(5):500-6. PubMed ID: 15851433 [TBL] [Abstract][Full Text] [Related]
11. Adverse psychiatric effects of systemic glucocorticoid therapy. Klein JF Am Fam Physician; 1992 Nov; 46(5):1469-74. PubMed ID: 1442465 [TBL] [Abstract][Full Text] [Related]
12. [Neuropsychiatric symptoms caused by mefloquine (report of several cases)]. Murai Z; Baran B; Tolna J; Szily E; Gazdag G Orv Hetil; 2005 Jan; 146(3):133-6. PubMed ID: 15693445 [TBL] [Abstract][Full Text] [Related]
13. The neuropsychiatric complications of glucocorticoid use: steroid psychosis revisited. Dubovsky AN; Arvikar S; Stern TA; Axelrod L Psychosomatics; 2012; 53(2):103-15. PubMed ID: 22424158 [TBL] [Abstract][Full Text] [Related]
14. An exploratory retrospective evaluation of ropinirole-associated psychotic symptoms in an outpatient population treated for restless legs syndrome or Parkinson's disease. Stoner SC; Dahmen MM; Makos M; Lea JW; Carver LJ; Rasu RS Ann Pharmacother; 2009 Sep; 43(9):1426-32. PubMed ID: 19690226 [TBL] [Abstract][Full Text] [Related]
15. Psychiatric manifestations accompanying interferon therapy for patients with chronic hepatitis C: an overview of cases in Japan. Nozaki O; Takagi C; Takaoka K; Takata T; Yoshida M Psychiatry Clin Neurosci; 1997 Aug; 51(4):175-80. PubMed ID: 9316160 [TBL] [Abstract][Full Text] [Related]
16. [Persecution syndrome after the use of interferon: a case report]. Lemonnier E; Condat B; Paillère-Martinot ML; Chollet R; Allilaire JF Ann Med Psychol (Paris); 1996 Jun; 154(4):246-8; discussion 248-9. PubMed ID: 8929053 [TBL] [Abstract][Full Text] [Related]
17. Psychosis with paranoid delusions after a therapeutic dose of mefloquine: a case report. Tran TM; Browning J; Dell ML Malar J; 2006 Aug; 5():74. PubMed ID: 16925829 [TBL] [Abstract][Full Text] [Related]
18. [Incidence, pathoetiology and treatment of interferon-alpha induced neuro-psychiatric side effects]. Schäfer M; Schwaiger M Fortschr Neurol Psychiatr; 2003 Sep; 71(9):469-76. PubMed ID: 12975732 [TBL] [Abstract][Full Text] [Related]